$FUL

HB Fuller earnings analysis: questions answered and next catalysts

H.B. Fuller (FUL) reported Q2 2026 earnings with adjusted EPS of $1.41, revenue of $950.3M, and raised FY2026 guidance. Q3 2026 showed an EPS beat but a revenue miss, with shares down 24.85% over three months. The £715M AMS acquisition and volume headwinds are key concerns. Analysts have mixed views on the stock's outlook.

Original reporting
Published Sep 24, 2026, 4:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 5:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FUL
Bearish
high confidence
Mentioned
$FUL
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FULBearishMed
01

Why it matters

The earnings miss and high leverage increase short‑term risk, while the acquisition offers long‑term margin upside if executed cleanly.

02

Market read

Investors should monitor the AMS shareholder vote, leverage trends, and Q4 guidance for potential price moves.

03

What to watch

Potential cost‑saving from the Quantum Leap restructuring and strong pricing power in a volatile raw‑material environment.

Relevance 8/10Novelty 8/10Timing: post‑Q3 earnings release (Sep 23) and AMS deal update (Sep 24)

Background

The article reviews H.B. Fuller's recent earnings, guidance, and the pending acquisition of Advanced Medical Solutions, highlighting operational performance and financial metrics.

Company-level read

Ticker impact

$FULBearishHigh confidence
Context

H.B. Fuller reported Q3 earnings with a slight EPS beat but a revenue miss and disclosed details of its $1B AMS acquisition, including leverage impact and integration timeline.

Expected impact

Potential further decline toward $45 if integration concerns persist; upside to $52 if Q4 guidance improves.

Evidence & confidence

The combination of a revenue shortfall, elevated leverage, and pending acquisition approval creates material uncertainty for investors.

Market effects

Adhesives and specialty chemicals sector may see pressure as peers evaluate high‑leverage acquisitions.

European markets could react to the UK takeover code implications for the AMS deal.

Limited to investors with exposure to mid‑cap industrial stocks.

Counterpoint

If the AMS synergies materialize faster than expected, leverage could drop and margin expansion may drive the stock above $55.

Key entities

  • H.B. Fuller

    US‑listed adhesives and specialty chemicals manufacturer (ticker FUL).

  • Advanced Medical Solutions (AMS)

    Target of a $1 billion all‑cash acquisition by H.B. Fuller.

Related articles

$FULHighAI 8/10

Is H.B. Fuller (FUL) Stock a Bargain After Q3 Earnings?

H.B. Fuller (FUL) reported Q3 revenue of $938M, up 5.2% YoY, with adjusted EPS surging 21%. The company raised full-year guidance, citing margin expansion and cost savings. However, sales volume declined 3%, raising concerns about demand. The stock trades at a forward P/E of 9.44x, reflecting mixed investor sentiment.

$FULMedAI 8/10

Why H.B. Fuller Stock Dipped on Thursday

H.B. Fuller (FUL) reported Q3 2026 net revenue of $938M, up 5% YoY, driven by a 7% price increase offsetting volume declines. GAAP net income rose 18% to $79.2M, and adjusted EPS beat estimates at $1.52. However, revenue missed expectations. The company maintained full-year revenue growth guidance and narrowed adjusted EPS guidance to $4.70-$4.85. Shares dipped slightly on the mixed results.

$FULMedAI 8/10

Fuller (FUL) Q3 2026 Earnings Call Transcript

Fuller (FUL) reported Q3 2026 net revenue of $938M, up 5.2% YoY, with adjusted EBITDA of $187M, up 9% YoY. Adjusted EPS rose 21% to $1.52. Organic revenue grew 4.4%, driven by pricing. Guidance for fiscal 2026 adjusted EBITDA and EPS was updated. Management highlighted Project Quantum Leap savings and the pending AMS acquisition. Risks include chip shortages and supply chain disruptions.

$FULHigh

FULLER H B CO (FUL): Results of Operations and Financial Condition

FULLER H B CO (FUL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Worldwide Headquarters 1200 Willow Lake Boulevard St. Paul, Minnesota 55110-5101 Scott Jensen Investor Relations Contact investors@hbfuller.com NEWS September 23, 2026 H.B. Fuller Reports Third Quarter 2026 Results Net revenue of $938 million, up 5.2% year-on-year; O